Basit öğe kaydını göster

Long-Term Efficacy and Safety of Everolimus as Adjunctive Therapy in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-Refractory Seizures: Final Analysis of the Exist-3 Study

dc.contributor.authorPelov, D.
dc.contributor.authorMookerjee, B.
dc.contributor.authorPeyrard, S.
dc.contributor.authorFrench, J.
dc.contributor.authorYapici, Z.
dc.contributor.authorPolster, T.
dc.contributor.authorFranz, D. N.
dc.contributor.authorLawson, J. A.
dc.contributor.authorIkeda, H.
dc.contributor.authorNabbout, R.
dc.contributor.authorCuratolo, P.
dc.contributor.authorde Vries, P. J.
dc.contributor.authorDlugos, D.
dc.contributor.authorFan, J.
dc.date.accessioned2021-03-05T18:12:41Z
dc.date.available2021-03-05T18:12:41Z
dc.identifier.citationPolster T., Franz D. N. , Lawson J. A. , Yapici Z., Ikeda H., Nabbout R., Curatolo P., de Vries P. J. , Dlugos D., Fan J., et al., "Long-Term Efficacy and Safety of Everolimus as Adjunctive Therapy in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-Refractory Seizures: Final Analysis of the Exist-3 Study", 13th European Congress on Epileptology, Vienna, Avusturya, 26 - 30 Ağustos 2018, cilt.59
dc.identifier.othervv_1032021
dc.identifier.otherav_c93ae394-37e1-46c1-a20a-1a753f856122
dc.identifier.urihttp://hdl.handle.net/20.500.12627/133341
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectNöroloji
dc.subjectKLİNİK NEUROLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.titleLong-Term Efficacy and Safety of Everolimus as Adjunctive Therapy in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-Refractory Seizures: Final Analysis of the Exist-3 Study
dc.typeBildiri
dc.contributor.departmentBethel Epilepsy Ctr , ,
dc.identifier.volume59
dc.contributor.firstauthorID155520


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster